Benitec Biopharma (BNTC) Profit After Tax (2019 - 2025)
Historic Profit After Tax for Benitec Biopharma (BNTC) over the last 7 years, with Q2 2025 value amounting to -$8.8 million.
- Benitec Biopharma's Profit After Tax fell 8462.99% to -$8.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$38.0 million, marking a year-over-year decrease of 7375.26%. This contributed to the annual value of -$37.9 million for FY2025, which is 7393.12% down from last year.
- As of Q2 2025, Benitec Biopharma's Profit After Tax stood at -$8.8 million, which was down 8462.99% from -$14.5 million recorded in Q1 2025.
- Benitec Biopharma's 5-year Profit After Tax high stood at -$3.3 million for Q1 2022, and its period low was -$14.5 million during Q1 2025.
- In the last 5 years, Benitec Biopharma's Profit After Tax had a median value of -$5.1 million in 2021 and averaged -$5.9 million.
- Per our database at Business Quant, Benitec Biopharma's Profit After Tax surged by 1621.9% in 2022 and then crashed by 23888.76% in 2025.
- Quarter analysis of 5 years shows Benitec Biopharma's Profit After Tax stood at -$4.8 million in 2021, then fell by 12.24% to -$5.4 million in 2022, then decreased by 25.63% to -$6.8 million in 2023, then tumbled by 40.51% to -$9.6 million in 2024, then rose by 7.82% to -$8.8 million in 2025.
- Its Profit After Tax stands at -$8.8 million for Q2 2025, versus -$14.5 million for Q1 2025 and -$9.6 million for Q4 2024.